Serial 97648644
Live / Applied — Statement of use — response to non-final action entered (as of 13 Jul 2026)
What this means for you
Not registered yet, but its 26 Oct 2022 filing date beats anything filed after it. If it registers, the owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 97648644
- Mark type
- Design / logo
- Filed
- 26 Oct 2022
- Published for opposition
- 25 Feb 2025
- Attorney of record
- Tara Reedy Sliva
Goods and services
- Class 001 — Chemicals: Biochemicals and organic chemicals used as enzyme substrates, enzyme inducers, namely, aminoglutethimides, carbamazepines, griseofulvins, and primidones, enzyme inactivators, or cultural medium additives for use in the field of microbiology and molecular biology for scientific purposes; biochemical and organic chemical reagents for clinical diagnostic laboratory use; biochemical and organic chemicals for use in the manufacture of pharmaceuticals and cosmetics; Chemical reagents for medical research use in the field of immunology
- Class 005 — Pharmaceuticals: Medicinal preparations, namely, photosensitizing agents used as a dermatologic drug for the treatment of skin cancer by phototherapy; Chemical reagents for medical or veterinarian use; Chemical reagents for use as culture media for cultures of microorganisms for medical use, namely, for the isolation and identification of the bacteria strain Escherichia coli O157:H7; Chemical preparations for medical purposes, namely, for Cholesterol testing to prevent possible consequences of Hypercholesterolemia such as atherosclerosis, coronary heart disease and other forms of cardiovascular diseases; Chemical preparations for medical purposes, namely, for novel enzyme responsive inhibitors that allow for modifications of the composition of microbial communities; Organic chemical preparations for medical purposes, namely, immunomodulators with anti-inflammatory properties; Organic chemical preparations and enzymes for medical laboratory analysis purposes, namely, for medical detection, identification and quantification of strains of pathogenic bacteria; Chemical preparations for medical laboratory analysis purposes, namely, for medical immunological and microbiological blood testing; Chemical preparations for medical laboratory analysis purposes, namely, for medical detection of pathogenic bacteria, namely, various strains of Listeria, Clostridium, Bacillus and Staphylococcus; Chemical preparations for medical laboratory analysis purposes, namely, for the medical detection and quantification of bacteria strains of Escherichia coli; Medical preparations for the diagnosis of Staphylococus aureus, in particular for Methicillin-resistant Staphylococcus aureus (MRSA); Chemical reagents for medical laboratory analysis purposes, namely, for use as a routine medical supplement to blood culture media in vitro to inhibit blood coagulation and to improve the detection limits for individual microorganisms
Owner
- Biosynth AG, Staad, CH
- Biosynth AG, Staad, CH
Prosecution history
- 09 Sept 2026 — ASSIGNED TO EXAMINER
- 13 Jul 2026 — TEAS/EMAIL CORRESPONDENCE ENTERED
- 13 Jul 2026 — CORRESPONDENCE RECEIVED IN LAW OFFICE
- 13 Jul 2026 — ASSIGNED TO LIE
- 09 Jul 2026 — TEAS RESPONSE TO OFFICE ACTION RECEIVED
- 09 Apr 2026 — NOTIFICATION OF NON-FINAL ACTION E-MAILED
- 09 Apr 2026 — NON-FINAL ACTION E-MAILED
- 09 Apr 2026 — SU - NON-FINAL ACTION - WRITTEN
- 08 Apr 2026 — STATEMENT OF USE PROCESSING COMPLETE
- 14 Oct 2025 — USE AMENDMENT FILED
- 06 Apr 2026 — CASE ASSIGNED TO INTENT TO USE PARALEGAL
- 15 Oct 2025 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 14 Oct 2025 — TEAS STATEMENT OF USE RECEIVED
- 14 Oct 2025 — SOU EXTENSION 1 GRANTED
- 14 Oct 2025 — SOU EXTENSION 1 FILED